Atlas Trials

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

30 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

RecordFirmDate
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease (NCT03323476)Centre Hospitalier Departemental Vendee2018-02-02
A Study of CCX168 in Japanese and Caucasian Healthy Adult Males (NCT05988008)Amgen2017-10-23
Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing (NCT02749292)Massachusetts General Hospital2016-06-01
A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications (NCT06004947)Amgen2016-01-14
A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168 (NCT05988021)Amgen2015-12-03
A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants (NCT06004960)Amgen2014-10-20
Low-dose Glucocorticoid Vasculitis Induction Study (NCT02198248)Chiba University2014-10-01
Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation (NCT02180126)Hillel Yaffe Medical Center2014-08-01
The Clinical Efficacy of DFPP in Patients With AAGN (NCT02294344)Zhi-Hong Liu, M.D.2014-06-01
Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease. (NCT04413149)Peking Union Medical College Hospital2014-04-01
Rituximab Vasculitis Maintenance Study (NCT01697267)Cambridge University Hospitals NHS Foundation Trust2013-04-01
Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab (NCT01275287)University of North Carolina, Chapel Hill2011-05-01

Track Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis automatically

Every clearance here is in the API, with alerts when new ones post.